CLINICAL_TRIALS
trial_result
· 2018-01-19
Clinical Trial Update: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment [Phase 4]
Summary
Phase 4 trial comparing extended-release naltrexone to buprenorphine for opioid use disorder has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-01-19